7QCB

Williams-Beuren syndrome related methyltransferase WBSCR27 in complex with SAH


SOLUTION NMR
NMR Experiment
ExperimentTypeSample ContentsSolventIonic StrengthpHPressureTemperature (K)Spectrometer
12D 1H-15N HSQC1.0 mM [U-15N] WBSCR27, 10 mM SAH, 5 mM DTT, 0.2 % w/v sodium azide, 50 mM sodium phosphate, 50 mM sodium chloride95% H2O/5% D2O100 mM7.001 atm308Bruker AVANCE 600
22D 1H-15N HSQC0.6 mM [U-95% 13C; U-99% 15N] WBSCR27, 0.6 mM SAH, 5 mM DTT, 0.2 % w/v sodium azide, 50 mM sodium phosphate, 50 mM sodium chloride100% D2O100 mM7.001 atm308Bruker AVANCE 850
33D HNCO0.6 mM [U-95% 13C; U-99% 15N] WBSCR27, 0.6 mM SAH, 5 mM DTT, 0.2 % w/v sodium azide, 50 mM sodium phosphate, 50 mM sodium chloride95% H2O/5% D2O100 mM7.001 atm308Bruker AVANCE 850
43D HNCACO0.6 mM [U-95% 13C; U-99% 15N] WBSCR27, 0.6 mM SAH, 5 mM DTT, 0.2 % w/v sodium azide, 50 mM sodium phosphate, 50 mM sodium chloride95% H2O/5% D2O100 mM7.001 atm308Bruker AVANCE 850
53D HN(CO)CA0.6 mM [U-95% 13C; U-99% 15N] WBSCR27, 0.6 mM SAH, 5 mM DTT, 0.2 % w/v sodium azide, 50 mM sodium phosphate, 50 mM sodium chloride95% H2O/5% D2O100 mM7.001 atm308Bruker AVANCE 850
63D HNCA0.6 mM [U-95% 13C; U-99% 15N] WBSCR27, 0.6 mM SAH, 5 mM DTT, 0.2 % w/v sodium azide, 50 mM sodium phosphate, 50 mM sodium chloride95% H2O/5% D2O100 mM7.001 atm308Bruker AVANCE 850
73D CBCA(CO)NH0.6 mM [U-95% 13C; U-99% 15N] WBSCR27, 0.6 mM SAH, 5 mM DTT, 0.2 % w/v sodium azide, 50 mM sodium phosphate, 50 mM sodium chloride95% H2O/5% D2O100 mM7.001 atm308Bruker AVANCE 850
83D HNCACB0.6 mM [U-95% 13C; U-99% 15N] WBSCR27, 0.6 mM SAH, 5 mM DTT, 0.2 % w/v sodium azide, 50 mM sodium phosphate, 50 mM sodium chloride95% H2O/5% D2O100 mM7.001 atm308Bruker AVANCE 850
93D HBHA(CO)NH0.6 mM [U-95% 13C; U-99% 15N] WBSCR27, 0.6 mM SAH, 5 mM DTT, 0.2 % w/v sodium azide, 50 mM sodium phosphate, 50 mM sodium chloride95% H2O/5% D2O100 mM7.001 atm308Bruker AVANCE 850
103D HNHAHB0.6 mM [U-95% 13C; U-99% 15N] WBSCR27, 0.6 mM SAH, 5 mM DTT, 0.2 % w/v sodium azide, 50 mM sodium phosphate, 50 mM sodium chloride95% H2O/5% D2O100 mM7.001 atm308Bruker AVANCE 850
113D 1H-15N TOCSY0.6 mM [U-95% 13C; U-99% 15N] WBSCR27, 0.6 mM SAH, 5 mM DTT, 0.2 % w/v sodium azide, 50 mM sodium phosphate, 50 mM sodium chloride95% H2O/5% D2O100 mM7.001 atm308Bruker AVANCE 850
123D HCCH-TOCSY0.6 mM [U-95% 13C; U-99% 15N] WBSCR27, 0.6 mM SAH, 5 mM DTT, 0.2 % w/v sodium azide, 50 mM sodium phosphate, 50 mM sodium chloride100% D2O100 mM7.001 atm308Bruker AVANCE 850
133D 1H-13C NOESY0.6 mM [U-95% 13C; U-99% 15N] WBSCR27, 0.6 mM SAH, 5 mM DTT, 0.2 % w/v sodium azide, 50 mM sodium phosphate, 50 mM sodium chloride100% D2O100 mM7.001 atm308Bruker AVANCE 850
143D 1H-13C NOESY0.6 mM [U-95% 13C; U-99% 15N] WBSCR27, 0.6 mM SAH, 5 mM DTT, 0.2 % w/v sodium azide, 50 mM sodium phosphate, 50 mM sodium chloride95% H2O/5% D2O100 mM7.001 atm308Bruker AVANCE 700
153D 15N-1H NOESY0.6 mM [U-95% 13C; U-99% 15N] WBSCR27, 0.6 mM SAH, 5 mM DTT, 0.2 % w/v sodium azide, 50 mM sodium phosphate, 50 mM sodium chloride95% H2O/5% D2O100 mM7.001 atm308Bruker AVANCE 850
16IPAP0.2 mM [U-15N] WBSCR27, 10 mM SAH, 5 mM DTT, 0.2 % w/v sodium azide, 50 mM sodium phosphate, 50 mM sodium chloride, 0.225 % v/v phage Pf1 stock solution95% H2O/5% D2O100 mM7.001 atm308Bruker AVANCE 800
173D 15N-1H NOESY0.3 mM [U-95% 15N] WBSCR27, 0.3 mM [U-95% 13C; U-99% 15N] SAH, 5 mM DTT, 0.2 % w/v sodium azide, 50 mM sodium phosphate, 50 mM sodium chloride95% H2O/5% D2O100 mM7.001 atm308Bruker AVANCE 800
182D 1H-13C HSQC0.3 mM [U-95% 15N] WBSCR27, 0.3 mM [U-95% 13C; U-99% 15N] SAH, 5 mM DTT, 0.2 % w/v sodium azide, 50 mM sodium phosphate, 50 mM sodium chloride100% D2O100 mM7.001 atm308Bruker AVANCE 700
192D DQF-COSY1.0 mM [U-15N] WBSCR27, 10 mM SAH, 5 mM DTT, 0.2 % w/v sodium azide, 50 mM sodium phosphate, 50 mM sodium chloride95% H2O/5% D2O100 mM7.001 atm308Bruker AVANCE 600
NMR Spectrometer Information
SpectrometerManufacturerModelField Strength
1BrukerAVANCE600
2BrukerAVANCE850
3BrukerAVANCE800
5BrukerAVANCE700
4BrukerAVANCE700
NMR Refinement
MethodDetailsSoftware
simulated annealingCNS
NMR Ensemble Information
Conformer Selection Criteriastructures with the least restraint violations
Conformers Calculated Total Number200
Conformers Submitted Total Number20
Representative Model1 (closest to the average)
Computation: NMR Software
#ClassificationVersionSoftware NameAuthor
1collectionTopSpinBrunger A. T. et.al.
2peak pickingNMRFAM-SPARKYLee W, Tonelli M, Markley JL
3chemical shift assignmentPINE-SPARKYLee W
4chemical shift assignmentNMRFAM-SPARKYLee W, Tonelli M, Markley JL
5data analysisNMRFAM-SPARKYLee W, Tonelli M, Markley JL
6processingNMRPipeDelaglio, Grzesiek, Vuister, Zhu, Pfeifer and Bax
7processingNMRDrawDelaglio, Grzesiek, Vuister, Zhu, Pfeifer and Bax
8structure calculationARIALinge, O'Donoghue and Nilges
9refinementCNS2.21Brunger, Adams, Clore, Gros, Nilges and Read
10data analysisNMRestPolshakov V.